FDA Drug recall D-0402-2015
Quinapril Tablets USP, 40 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 502686911…
- FDA Drug
- Class III
- terminated
- Published 2015-03-11
On 2015-03-11 the FDA classified a Class III recall of Quinapril Tablets USP, 40 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 502686911… by Avkare, citing subpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0402-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-02-27 |
| Published | 2015-03-11 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Avkare |
| Distribution | US |
Product
Quinapril Tablets USP, 40 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 5026869115, NDC 50268-691-15
Reason
Subpotent Drug
Identifiers
| code_info | Lot number: I1407932, Exp. 02/2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0402-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.